Related Experiment Video
Updated: Jun 5, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Proteomic approaches in myeloid leukemia
Jitendra Kumar Kanaujiya1, Savita Lochab, Pooja Pal
1Drug Target Discovery and Development Division, Central Drug Research Institute, Lucknow, India.
Electrophoresis
|January 22, 2011
Summary
Proteomics is crucial for understanding myeloid leukemia by analyzing protein profiles. This approach aids in identifying new therapeutic targets and biomarkers for better disease management.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The human genome's completion necessitates protein characterization for biological understanding.
- Proteomics, the study of the proteome, is vital for identifying novel therapeutic targets.
- Comparing protein profiles in diseased versus healthy states is a key research focus.
Purpose of the Study:
- To review the application of proteomics in understanding myeloid leukemia.
- To highlight the role of proteomics in identifying therapeutic targets and biomarkers.
- To summarize recent advancements in myeloid leukemia proteomics.
Main Methods:
- Proteomic techniques for analyzing protein expression and interactions.
- Comparative analysis of protein profiles in myeloid leukemia.
- Identification of post-translational modifications (PTMs) and protein markers.
Main Results:
- Proteomics has identified various interacting proteins, target proteins, PTMs, and protein markers in myeloid leukemia.
- Proteomic data facilitates predictive mathematical models of biological systems.
- This approach aids in the rapid identification of novel therapeutic targets and biomarkers.
Conclusions:
- Proteomics is an essential technique for defining the myeloid leukemia proteome.
- Understanding the proteome enhances comprehension of the disease.
- Proteomics opens new avenues for developing improved therapeutics for myeloid leukemia.
